87
Views
1
CrossRef citations to date
0
Altmetric
Original Research

How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?

, &
Pages 989-998 | Published online: 03 Feb 2021

References

  • Apuri S. Neoadjuvant and adjuvant therapies for breast cancer. South Med J. 2017;110(10):638–642. doi:10.14423/SMJ.000000000000070328973704
  • Bleicher RJ. Timing and delays in breast cancer evaluation and treatment. Ann Surg Oncol. 2018;25(10):2829–2838. doi:10.1245/s10434-018-6615-229968031
  • Omarini C, Guaitoli G, Noventa S, et al. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients. Eur J Surg Oncol. 2017;43(4):613–618. doi:10.1016/j.ejso.2016.09.02027793416
  • Suleman K, Almalik O, Haque E, et al. Does the timing of surgery after neoadjuvant therapy in breast cancer patients affect the outcome? Oncology. 2020;98(3):168–173. doi:10.1159/00050496431918425
  • Radovanovic Z, Ranisavljevic M, Radovanovic D, et al. Nipple-sparing mastectomy with primary implant reconstruction: surgical and oncological outcome of 435 breast cancer patients. Breast Care. 2018;13(5):373–378. doi:10.1159/00048931730498425
  • Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from national surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monogr. 2001;30(30):96–102. doi:10.1093/oxfordjournals.jncimonographs.a003469
  • Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol. 2003;21(22):4165–4174. doi:10.1200/JCO.2003.12.00514559892
  • Gagliato D, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014;32(8):735–744. doi:10.1200/JCO.2013.49.769324470007
  • Sanford RA, Lei X, Barcenas CH, et al. Impact of time from completion of neoadjuvant chemotherapy to surgery on survival outcomes in breast cancer patients. Ann Surg Oncol. 2016;23(5):1515–1521. doi:10.1245/s10434-015-5020-326678405
  • Falcone RE, Nappi JF. Chemotherapy and wound healing. Surg Clin. 1984;64(4):779–794. doi:10.1016/S0039-6109(16)43394-3
  • Trojan TP, Trojan J, Bechstein W, Woeste G. Impact of neoadjuvant chemotherapy on postoperative morbidity after gastrectomy for gastric cancer. Dig Surg. 2015;32(4):229–237. doi:10.1159/00038188425966823
  • Berkel AE, Woutersen DP, van der Palen J, et al. Prognostic factors for postoperative morbidity and tumour response after neoadjuvant chemoradiation followed by resection for rectal cancer. J Gastrointest Surg. 2014;18(9):1648–1657. doi:10.1007/s11605-014-2559-424939597
  • Sutton TL, Johnson N, Schlitt A, et al. Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates. Am J Surg. 2020;219(5):741–745.32200974
  • Song J, Zhang X, Liu Q, et al. Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis. PLoS One. 2014;9(5):e98225. doi:10.1371/journal.pone.009822524878776
  • Müller C, Juhasz Böss I, Schmidt G, et al. Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients. Arch Gynecol Obstet. 2020;301(4):1055–1059. doi:10.1007/s00404-020-05494-632170410
  • Zhang M, Sun S, Mesurolle B. The impact of pre-operative breast MRI on surgical waiting time. PLoS One. 2017;12:1–10.